Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

0.4541 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q12019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 19.13111.89110.95613.01111.34310.2268.10917.79511.459.8998.7217.1599.53315.599169.41816.5963.733-0.2510.251
Short Term Investments 27.8740.39847.12552.74660.6768.61487.39689.321105.108113.815127.503140.462147.129146.8990000.5020
Cash and Short Term Investments 47.00152.28958.08165.75772.01378.848.10917.795116.558123.714136.224147.6219.53315.599169.41816.5963.7330.2510.251
Net Receivables 0000000000000000000
Inventory 0000000000000000000
Other Current Assets 1.0971.6552.1531.4931.8232.2293.1031.4731.9243.7772.7530.9211.53.1153.3673.480.69600.251
Total Current Assets 48.09853.94460.23467.2572.01381.06998.608108.589118.482127.491138.977148.542158.162165.613172.78520.0764.4290.2510.502
Non-Current Assets:
Property, Plant & Equipment, Net 5.0695.7686.3757.0387.7368.4259.2449.72410.27610.511.0224.6443.062.1111.6551.2661.0500.268
Goodwill 0000000000000000000
Intangible Assets 0000000000000000000
Goodwill and Intangible Assets 0000000000000000000
Long Term Investments 0000000000000000000
Tax Assets 0000000000000000000
Other Non-Current Assets 0.0870.0870.0860.0861.9090.0860.0810.0630.0450.0450.0390.0390.02700.0360.0860.036-0.2510.447
Total Non-Current Assets 5.1565.8556.4617.1249.6458.5119.3259.78710.32110.54511.0614.6833.0872.1111.6911.3521.086-0.2510.715
Total Assets 53.25459.79966.69574.37481.65889.58107.933118.375128.803138.036150.038153.225161.249167.724174.47621.4285.51501.217
Liabilities & Equity:
Current Liabilities:
Account Payables 01.64621.6942.7272.3294.7154.4734.6572.4235.12.4563.4932.8281.9713.8820.97403.451
Short Term Debt 2.4344.912.4784.8784.8124.6264.572.1314.1463.9843.8921.360000.0322.489016.055
Tax Payables 0000000000000000000
Deferred Revenue 0000-2.727-2.329-4.715-4.4730-2.423-5.100000.3490.98102.083
Other Current Liabilities 3.007-1.6070.514-0.929-1.313-1.598-1.7022.462-0.311-0.973-1.3861.0731.7711.0950.5040.9161.25202.208
Total Current Liabilities 5.4414.9494.9925.6436.2265.3577.5839.0668.4925.4347.6064.8895.2643.9232.4754.834.715021.714
Non-Current Liabilities:
Long Term Debt 2.0342.5913.1613.7694.3654.955.4665.9026.3256.6867.1241.67400.5670.5670.6530.56700
Deferred Revenue Non-Current 0000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000
Other Non-Current Liabilities 00.0670.0680.0670.0670.0720.03400000.1490.7770.1090.1820.05251.914048.165
Total Non-Current Liabilities 2.0342.6583.2293.8364.4325.0225.55.9026.3256.6867.1241.8230.7770.6760.74973.04152.481048.165
Total Liabilities 7.4757.6078.2219.47910.65810.37913.08314.96814.81712.1214.736.7126.0414.5993.22477.87157.196069.879
Equity:
Preferred Stock 000000000000161.2490174.47672.33651.78847.54547.545
Common Stock 0.0030.0030.0030.0030.0020.0030.0030.0030.0030.0030.0030.0030.0030.0030.00300.00900
Retained Earnings -254.282-247.029-239.887-231.895-224.481-217.357-207.971-197.794-185.562-172.146-161.611-149.206-139.84-130.155-120.384-112.412-107.2810-92.312
Accumulated Other Comprehensive Income/Loss 0.014-0.093-0.137-0.209-0.402-0.549-0.823-1.004-1.205-1.212-0.899-0.333-0.069-0.101-174.4760-0.009-68.662-0.387
Other Total Stockholders Equity 300.044299.311298.495296.996295.881297.104303.641302.202300.75299.271297.815296.049295.114293.378466.10955.96955.6090-23.508
Total Shareholders Equity 45.77952.19258.47464.8957179.20194.85103.407113.986125.916135.308146.513155.208163.125171.252-56.443-51.681-21.117-68.662
Total Equity 45.77952.19258.47464.8957179.20194.85103.407113.986125.916135.308146.513155.208163.125171.252-56.443-51.681-21.117-68.662
Total Liabilities & Shareholders Equity 53.25459.79966.69574.37481.65889.58107.933118.375128.803138.036150.038153.225161.249167.724174.47621.4285.515-21.1171.217